Michael Stromquist
Lawyers
Represents issuers, financial institutions and investors in a variety of public and private capital markets transactions.
Michael represents issuers, financial institutions and investors in a variety of public and private capital markets transactions. These include equity offerings (IPOs, follow-on equity offerings, private placements and at-the-market offerings), investment-grade and high-yield debt offerings, and liability management transactions. He also advises clients on general corporate, securities law compliance and governance matters. Michael’s transactional practice spans a broad spectrum of industries, including manufacturing, TMT, healthcare and life sciences, fintech, transportation, retail and energy.
Experience highlights
Recent Representations
- MicroStrategy $603.75 million convertible notes offering
- MicroStrategy $800 million convertible notes offering
- Intercontinental Exchange consent solicitation
- Synchrony Financial $500 million preferred stock offering
- Kyndryl $500 million senior notes offering
- Solid Biosciences $109 million private placement
- Samarco Mineração restructuring
- MicroStrategy $750 million at-the-market offering
- TKO Group Holdings $666 million secondary offering
- Allego warrant exchange offer
- MicroStrategy $750 million at-the-market offering
- Editas Medicine $125 million follow-on offering
- TH International warrant exchange offer
- Verisk $500 million senior notes offering
- Bombardier cash tender offer
- Bombardier $750 million senior notes offering
Education
J.D., New York University School of Law
- Articles Editor, N.Y.U. Journal of Legislation & Public Policy
B.S.B.A., Economics, University of Florida
Professional history
- Counsel, 2024-present
- Davis Polk since 2021
- Associate, Fried Frank Harris Shriver & Jacobson, 2019-2021
- Associate, Schulte Roth & Zabel, 2014-2019
Qualifications and admissions
- State of New York